Summary

DESCRIPTION

Short Description
Australia HPB Surgery Market, By Application (Tumor Resection and Treatment, Laparoscopic Cholecystectomy, and Others), Technology (Laparoscopic Systems & Robotic Assisted Tools, Intraoperative Ultrasound Systems For Tumor Localization, Electrosurgical and Energy-Based Devices, and Advanced Imaging Systems), Procedure Type (Laparoscopic Surgery, Robotic-Assisted Surgery, and Open Surgery), End User, (Hospitals, Specialty Cancer Hospitals, Ambulatory Surgical Centers (ASC), and Others) - Industry Trends and Forecast to 2032
Market Definition:

Hepatopancreatobiliary (HPB) surgery refers to a specialized branch of surgical medicine that focuses on the diagnosis, treatment, and surgical management of disorders related to the liver, pancreas, gallbladder, and biliary tract. This field encompasses a wide range of complex procedures, including liver resections, pancreaticoduodenectomies (Whipple procedures), cholangiocarcinoma resections, and surgeries addressing various forms of liver disease, including tumors, infections, and liver transplants. HPB surgery is typically performed by surgeons with advanced training in surgical oncology and hepatobiliary surgery, and it often involves multidisciplinary approaches to ensure comprehensive patient care, integrating the expertise of gastroenterologists, oncologists, radiologists, and pathologists. The goal of HPB surgery is to improve clinical outcomes and enhance quality of life for patients suffering from various HPB-related conditions.
Market Segmentation:
Australia HPB Surgery Market segmentation based on application, procedure type, technology, and end user, in the Australia HPB Surgery Market and upcoming products are not considered while driving the market.
• On the basis of application, the market is segmented into tumor resection and treatment, laparoscopic cholecystectomy, and others
• On the basis of procedure type, the market is segmented into laparoscopic systems & robotic assisted tools, intraoperative ultrasound systems for tumor localization, electrosurgical and energy-based devices, and advanced imaging systems
• On the basis of technology, the market is segmented into laparoscopic surgery, robotic-assisted surgery, and open surgery
• On the basis of end user, Europe self-injections market is segmented into hospitals , specialty cancer hospitals, ambulatory surgical centers(ACS), and others
Market Players

Some of the major players operating in Australia HPB surgery market are:

• Medtronic
• Olympus Corporation
• Johnson & Johnson Services, Inc.
• SIEMENS HEALTHINEERS
• Boston Scientific Corporation
• FUJIFILM HOLDINGS CORPORATION
• GE Healthcare
• Intuitive Surgical Operations, Inc.
• KARL STORZ
• Stryker

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 10
1.1 OBJECTIVES OF THE STUDY 10
1.2 MARKET DEFINITION 10
1.3 OVERVIEW OF THE AUSTRALIA HPB SURGERY MARKET 10
1.4 LIMITATIONS 11
1.5 MARKETS COVERED 11
2 MARKET SEGMENTATION 13
2.1 MARKETS COVERED 13
2.2 GEOGRAPHICAL SCOPE 14
2.3 YEARS CONSIDERED FOR THE STUDY 14
2.4 CURRENCY AND PRICING 14
2.5 DBMR TRIPOD DATA VALIDATION MODEL 15
2.6 MULTIVARIATE MODELING 18
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 19
2.8 DBMR MARKET POSITION GRID 20
2.9 MARKET END USER COVERAGE GRID 21
2.10 DBMR VENDOR SHARE ANALYSIS 22
2.11 SECONDARY SOURCES 23
2.12 ASSUMPTIONS 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 28
4.1 PESTAL ANALYSIS 29
4.2 PORTERS FIVE FORCES ANALYSIS 30
4.3 HEALTHCARE EXPENDITURE WITH A FOCUS ON HPB SURGERY 31
4.3.1 PROCEDURES: 31
4.3.2 CHOLECYSTECTOMY 31
4.3.3 COLONOSCOPY 32
4.4 HEPATO-PANCREATO-BILIARY SURGERY VOLUME TREND 33
4.5 EPIDEMIOLOGY 34
5 MARKET OVERVIEW 35
5.1 DRIVERS 37
5.1.1 INCREASING NUMBER OF DISEASES ASSOCIATED WITH THE LIVER AND PANCREAS 37
5.1.2 GROWING TREND OF GALL BLADDER CONCERNS IN YOUNGER ADULTS 37
5.1.3 TECHNOLOGICAL ADVANCEMENTS IN ELECTROSURGERY INSTRUMENTS 38
5.1.4 RISE OF MINIMALLY INVASIVE SUSRGERY 38
5.2 RESTRAINTS 40
5.2.1 RISING ATTENTION TO HEALTHY DIET 40
5.2.2 CONCERNS ASSOCIATED WITH POST-SURGERY COMPLICATIONS 40
5.2.3 INCORPORATION OF AI TECHNOLOGY IN SURGICAL DEVICES 41
5.2.4 INCREASING COLLABORATIONS AND PARTNERSHIPS 41
5.2.5 INCREASED NUMBER OF TRAINING AND EDUCATION PROGRAMS 42
5.3 CHALLENGES 43
5.3.1 LACK OF PROPER HEALTHCARE FACILITIES IN DEVELOPING REGION 43
5.3.2 SHORTAGE OF TRAINED PROFESSIONALS 43
6 AUSTRALIA HPB SURGERY MARKET, BY APPLICATION 44
6.1 OVERVIEW 45
6.2 TUMOR RESECTION AND TREATMENT 48
6.2.1 LIVER TUMORS 48
6.2.1.1 HEPATOCELLULAR CARCINOMA 48
6.2.1.2 METASTASIS 48
6.2.2 PANCREATIC TUMORS 49
6.2.2.1 PANCREATIC ADENOCARCINOMA 49
6.2.2.2 NEUROENDOCRINE TUMORS 49
6.2.3 BILIARY TRACT CANCERS 49
6.2.3.1 CHOLANGIOCARCINOMA 49
6.2.3.2 GALLBLADDER CARCINOMA 49
6.3 LAPAROSCOPIC CHOLECYSTECTOMY 50
6.4 OTHERS 50
7 AUSTRALIA HPB SURGERY MARKET, BY TECHNOLOGY 51
7.1 OVERVIEW 52
7.2 LAPAROSCOPIC SYSTEMS & ROBOTIC ASSISTED TOOLS 55
7.3 INTRAOPERATIVE ULTRASOUND SYSTEMS FOR TUMOR LOCALIZATION 55
7.4 ELECTROSURGICAL AND ENERGY-BASED DEVICES 55
7.5 ADVANCED IMAGING SYSTEMS 55
8 AUSTRALIA HPB SURGERY MARKET, BY PROCEDURE TYPE 56
8.1 OVERVIEW 57
8.2 LAPAROSCOPIC SURGERY 60
8.3 OPEN SURGERY 60
8.4 ROBOTIC-ASSISTED SURGERY 60
9 AUSTRALIA HPB SURGERY MARKET, BY END USER 61
9.1 OVERVIEW 62
9.2 HOSPITALS 65
9.3 SPECIALITY CANCER HOSPITALS 65
9.4 AMBULATORY SURGICAL CENTERS(ACS) 65
9.5 OTHERS 65
10 AUSTRALIA HPB SURGERY MARKET: COMPANY LANDSCAPE 66
10.1 COMPANY SHARE ANALYSIS: AUSTRALIA 66
11 SWOT ANALYSIS 67
12 COMPANY PROFILES 68
12.1 MEDTRONIC 68
12.1.1 COMPANY SNAPSHOT 68
12.1.2 REVENUE ANALYSIS 68
12.1.3 PRODUCT PORTFOLIO 69
12.1.4 RECENT DEVELOPMENT 70
12.2 OLYMPUS CORPORATION 71
12.2.1 COMPANY SNAPSHOT 71
12.2.2 REVENUE ANALYSIS 71
12.2.3 PRODUCT PORTFOLIO 72
12.2.4 RECENT DEVELOPMENT 73
12.3 JOHNSON & JOHNSON SERVICES, INC 74
12.3.1 COMPANY SNAPSHOT 74
12.3.2 REVENUE ANALYSIS 74
12.3.3 PRODUCT PORTFOLIO 75
12.3.4 RECENT DEVELOPMENTS 75
12.4 SIEMENS HEALTHINEERS 77
12.4.1 COMPANY SNAPSHOT 77
12.4.2 REVENUE ANALYSIS 77
12.4.3 PRODUCT PORTFOLIO 78
12.4.4 RECENT DEVELOPMENT 79
12.5 BOSTON SCIENTIFIC CORPORATION 80
12.5.1 COMPANY SNAPSHOT 80
12.5.2 REVENUE ANALYSIS 80
12.5.3 PRODUCT PORTFOLIO 81
12.5.4 RECENT DEVELOPMENT 81
12.6 FUJIFILM HOLDINGS CORPORATION 83
12.6.1 COMPANY SNAPSHOT 83
12.6.2 REVENUE ANALYSIS 83
12.6.3 PRODUCT PORTFOLIO 84
12.6.4 RECENT DEVELOPMENT 84
12.7 GE HEALTHCARE 85
12.7.1 COMPANY SNAPSHOT 85
12.7.2 REVENUE ANALYSIS 85
12.7.3 PRODUCT PORTFOLIO 86
12.7.4 RECENT DEVELOPMENT 86
12.8 INTUITIVE SURGICAL OPERATIONS, INC. 87
12.8.1 COMPANY SNAPSHOT 87
12.8.2 REVENUE ANALYSIS 87
12.8.3 PRODUCT PORTFOLIO 88
12.8.4 RECENT DEVELOPMENT 88
12.9 KARL STORZ 89
12.9.1 COMPANY SNAPSHOT 89
12.9.2 PRODUCT PORTFOLIO 89
12.9.3 RECENT DEVELOPMENT 90
12.10 STRYKER 91
12.10.1 COMPANY SNAPSHOT 91
12.10.2 REVENUE ANALYSIS 91
12.10.3 PRODUCT PORTFOLIO 92
12.10.4 RECENT DEVELOPMENT 92
13 QUESTIONNAIRE 93
14 RELATED REPORTS 96